Cancer statistics in Europe are stark: according to the World Health Organisation (WHO), the disease causes 20 % of deaths in the European Region. With more than 3 million new cases and 1.7 million deaths each year, cancer is the most important cause of death and morbidity in Europe after cardiovascular diseases.
However, most of us don’t have to look to the statistics to be
convinced. The majority of Europeans have been touched by cancer in some
way, whether through friends, family or personal experience. We know
that cancer enters lives indiscriminately and can have devastating
effects. What we also now know that cancer is in many cases avoidable,
and early detection increases the chance of cure substantially.
In fact, WHO says that enough is already known about the causes to
prevent at least one third of all cancers, and some of the most common
types – including breast, colorectal and cervical cancer – can be cured
if detected early.
This knowledge has come about through intense research efforts which
have also led to the development of successful anti-cancer therapies
and treatments. Horizon 2020 is supporting emerging endeavours in this
area under the challenge of
Health, Demographic Change and Wellbeing.
Among other things, research and innovation supported by this call aims
to improve our understanding of the causes and mechanisms underlying
disease; and improve our ability to monitor health and to prevent,
detect, treat and manage disease.
Not only will research efforts feed into improving detection and
treatment, they will also help influence policy. The EU’s
recently-established Expert Group on Cancer Control intends to use this
kind of research when assisting the Commission in the drawing up of
legal instruments and policy documents, guidelines and recommendations
on cancer control.